Trial Details
RECRUITINGBasic Information
| Clinical ID | c156 |
|---|---|
| Identifier | NCT07078994 |
| Trial Title | Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease (CD) |
| Interventions | BIOLOGICAL: anti-TL1A monoclonal antibody, low dose|BIOLOGICAL: anti-TL1A monoclonal antibody, medium dose|BIOLOGICAL: anti-TL1A monoclonal antibody, high dose|OTHER: Placebo |
Participant Information
| Sponsor | Biocad |
|---|---|
| City | Altayskiy Kray |
| Country/Region | Russia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-08-14 |
|---|---|
| Primary Completion Date | 2027-05 |
| Completion Date | 2029-01 |